Somewhere between breakfast and whatever you ate last, your meals delivered roughly fifteen times more omega-6 than omega-3 to the enzyme pathways that regulate inflammation. Human biology was built for something closer to equal — a ratio near 1 to 1 that held for most of evolutionary history.
Omega-6 and omega-3 fatty acids compete for the same set of enzymes. When one side overwhelms the other, the biochemical output shifts — and the direction it shifts determines whether inflammation inside your cells escalates or resolves.
How the Omega-3 to Omega-6 Ratio Controls Inflammation
The omega-6 to omega-3 ratio in your diet controls which inflammatory compounds your cells produce through shared enzyme pathways. A 2026 meta-analysis found omega-3 supplements alone failed to reduce most inflammatory markers. Clinical evidence points to a dietary ratio between 1 to 1 and 4 to 1, achievable only by reducing omega-6 intake alongside increasing omega-3.
— Huang et al. 2026 · Front. Nutr. · 9 RCTs, n=504 | Simopoulos 2002 · Biomed Pharmacother
The competition plays out through two enzyme families — cyclooxygenase and lipoxygenase — that both types of fat share. Omega-6 passes through these enzymes and produces compounds that promote blood clotting, constrict blood vessels, and ramp up immune signaling. Omega-3 passes through the same enzymes and produces compounds that do the opposite — resolve inflammation, relax blood vessels, quiet the immune response. Whichever fat arrives in greater quantity captures more enzymatic attention.
A second bottleneck sits even earlier in the chain. Before either fat can become the longer-chain molecules involved in inflammatory signaling, both must pass through a single rate-limiting enzyme. It processes whatever arrives first and in greatest volume. Flood it with omega-6 from cooking oils and processed food, and omega-3 conversion slows to a fraction of what your intake would otherwise allow.
Across nine randomized trials, omega-3 supplements failed to reduce three of four key inflammatory signals. The markers that track systemic, low-grade inflammation — including C-reactive protein — stayed flat compared to placebo. The one marker that improved was driven by the omega-6 supplement group, not omega-3. Taking more of one side without addressing the other left the ratio unchanged — and the inflammatory output with it.
The supplement entered the competition. It entered outnumbered fifteen to one.
BLAMED: Insufficient omega-3 intake
ACTUAL: The total dietary omega-6 to omega-3 ratio — a two-sided competition where one-sided supplementation leaves the ratio unchanged
Clinical trials that shifted the dietary ratio itself — changing the food, not just adding a supplement — produced results supplementation alone could not. When the ratio dropped, the competition shifted: omega-3 captured a larger share of enzymatic output, and the inflammatory balance tipped. Across multiple conditions, outcomes improved when the ratio moved from Western double digits into a range between 1 to 1 and 4 to 1 — lower ratio, less inflammation, consistently.
Most of that ratio evidence comes from populations managing cardiovascular disease or autoimmune conditions — not people training for muscle or fat loss. Whether the same targets produce the same inflammatory shifts in a healthy, active body remains an unanswered question.
The mechanism does not depend on the population: two fats share one enzyme set, and daily meals determine which side wins. Changing the supplement doesn’t change the ratio — and the muscle benefit it promises faces its own evidence gap. Changing the kitchen does, starting with the oils that loaded one side and the choices that decide what a surplus builds. The question your supplement bottle never asked is what everything else you ate today is sending through those same enzymes.